Literature DB >> 2782373

Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis.

M Nose1, M Nishimura, M Kyogoku.   

Abstract

MRL/Mp mice bearing the lymphoproliferation gene (lpr) spontaneously develop systemic granulomatous arteritis coincident with glomerulonephritis (GNP). Although the association of lpr-dependent lymphoproliferation in these mice seems to be a prerequisite for the development of granulomatous arteritis, the genetic basis is poorly understood. The first approach to this problem was to study the ability of another, nonallelic, lymphoproliferative gene, gld (generalized lymphoproliferative disease), inducing arteritis in MRL/Mp mice. The gld gene was placed on an MRL/Mp background by producing reciprocal (MRL/Mp-+/+ X C3H/Hej-gld/gld)F2 hybrid mice. Seventeen percent of these mice with lymphoproliferation had arteritis and GNP, suggesting that more than one lymphoproliferative gene could induce GNP and arteritis in an MRL/Mp background. Next, the effect of rearrangements in the genetic background of MRL/Mp-lpr/lpr mice by hybridization with non-autoimmune lpr-bearing mice was examined. This was done by making MRL/Mp-lpr/lpr X reciprocal (MRL/Mp-lpr/lpr X C57BL/6-lpr/lpr)F1 mice. Thirty-three percent of these mice developed arteritis, but one third of these did not get GNP, thus showing that susceptibility to arteritis was separate from GNP. The histopathologic features of the arteritis in both the F2 hybrids and the backcross mice were granulomatous and were identical to those seen in MRL/Mp-lpr/lpr mice. These findings suggested that it might be possible to dissociated two components (arteritis and GNP) of a severe autoimmune disease of MRL/Mp mice and to study their pathogenesis separately.

Entities:  

Mesh:

Year:  1989        PMID: 2782373      PMCID: PMC1879921     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

2.  Genetic studies of autoimmunity in New Zealand mice. III. Associations among anti-DNA antibodies, NTA, and renal disease in (NZB x NZW)F1 x NZW backcross mice.

Authors:  H Yoshida; A Kohno; K Ohta; S Hirose; N Maruyama; T Shirai
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

3.  Increase in macrophage Ia expression in autoimmune mice: role of the Ipr gene.

Authors:  V E Kelley; J B Roths
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

4.  Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset.

Authors:  H C Morse; W F Davidson; R A Yetter; E D Murphy; J B Roths; R L Coffman
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

5.  Pathological studies on the kidney of systemic arteritis. II. Animal model: comparative studies on the pathogenesis of arteritis and glomerulonephritis of SL/Ni and MRL/1.

Authors:  M Kyogoku; M Kawashima; M Nose; N Yaginuma; K Nagao
Journal:  Nihon Jinzo Gakkai Shi       Date:  1981-07

6.  Degenerative vascular disease and myocardial infarction in mice with lupus-like syndrome.

Authors:  L Accinni; F J Dixon
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

7.  Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.

Authors:  N Maruyama; F Furukawa; Y Nakai; Y Sasaki; K Ohta; S Ozaki; S Hirose; T Shirai
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

8.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

9.  Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.

Authors:  G J Prud'Homme; C L Park; T M Fieser; R Kofler; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene.

Authors:  D Wofsy; E D Murphy; J B Roths; M J Dauphinée; S B Kipper; N Talal
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  15 in total

1.  An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.

Authors:  M-C Zhang; N Misu; H Furukawa; Y Watanabe; M Terada; H Komori; T Miyazaki; M Nose; M Ono
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

Review 2.  Cryoglobulins and the immunopathological manifestations of autoimmune disease.

Authors:  A M Denman
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

3.  Arteritis in a novel congenic strain of mice derived from MRL/Lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody production.

Authors:  M Nose; M Nishimura; M R Ito; J Toh; T Shibata; T Sugisaki
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

4.  Alteration of DNA methylation levels in MRL lupus mice.

Authors:  M Mizugaki; T Yamaguchi; S Ishiwata; H Shindo; T Hishinuma; S Nozaki; M Nose
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

5.  Host modifier genes affect mouse autoimmunity induced by the lpr gene.

Authors:  Y Wang; M Nose; T Kamoto; M Nishimura; H Hiai
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

6.  Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism.

Authors:  H Kanno; M Nose; J Itoh; Y Taniguchi; M Kyogoku
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

7.  Nephritogenicity of the lprcg gene on the MRL background.

Authors:  M Kimura; Y Ogata; K Shimada; T Wakabayashi; H Onoda; T Katagiri; A Matsuzawa
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

8.  Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse.

Authors:  J Itoh; M Nose; S Takahashi; M Ono; S Terasaki; E Kondoh; M Kyogoku
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

9.  Immune complex-degradation ability of macrophages in MRL/Mp-lpr/lpr lupus mice and its regulation by cytokines.

Authors:  H Kanno; O Tachiwaki; M Nose; M Kyogoku
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

10.  A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice.

Authors:  Hisashi Oishi; Takahito Tsubaki; Tatsuhiko Miyazaki; Masao Ono; Masato Nose; Satoru Takahashi
Journal:  J Immunol       Date:  2013-01-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.